BLIN-01: Blinatumomab for high-risk, Philadelphia chromosome-negative acute lymphoblastic leukaemia

Bookmark and Share
Published: 23 Jun 2020
Views: 293
Rating:
Save
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

Dr Josep Ribera speaks to ecancer in an online interview for the virtual EHA 2020 meeting.

He discusses BLIN-01 trial which looks at blinatumomab use during consolidation in adult patients with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukaemia.

He outlines the trial design, results and toxicity profile.